Lv5
920 积分 2024-08-26 加入
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study
8小时前
待确认
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
21天前
已完结
Atrasentan in Patients with IgA Nephropathy
21天前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
21天前
已完结
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
27天前
已完结
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
27天前
已完结
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
1个月前
已完结
Risk-directed management of chronic kidney disease
1个月前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
1个月前
已完结
The role of complement in kidney disease
1个月前
已完结
皖公网安备34019202002308
